Monthly Archives: September 2017

Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

Authors: Monica Khurana, Shekhar S. Raj ABSTRACT Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin < … Continue reading

Posted in OJBD | Leave a comment